259 related articles for article (PubMed ID: 19706791)
21. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
[TBL] [Abstract][Full Text] [Related]
23. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
Qiao L; MacLean PS; You H; Schaack J; Shao J
Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
[TBL] [Abstract][Full Text] [Related]
24. EP
Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059
[TBL] [Abstract][Full Text] [Related]
25. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
26. Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats.
Morita I; Tanimoto K; Akiyama N; Naya N; Fujieda K; Iwasaki T; Yukioka H
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E264-E272. PubMed ID: 28143857
[TBL] [Abstract][Full Text] [Related]
27. Sam68 promotes hepatic gluconeogenesis via CRTC2.
Qiao A; Zhou J; Xu S; Ma W; Boriboun C; Kim T; Yan B; Deng J; Yang L; Zhang E; Song Y; Ma YC; Richard S; Zhang C; Qiu H; Habegger KM; Zhang J; Qin G
Nat Commun; 2021 Jun; 12(1):3340. PubMed ID: 34099657
[TBL] [Abstract][Full Text] [Related]
28. E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes.
Giralt A; Denechaud PD; Lopez-Mejia IC; Delacuisine B; Blanchet E; Bonner C; Pattou F; Annicotte JS; Fajas L
Mol Metab; 2018 May; 11():104-112. PubMed ID: 29526568
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
30. Effect of chronic p,p'-dichlorodiphenyldichloroethylene (DDE) exposure on high fat diet-induced alterations in glucose and lipid metabolism in male C57BL/6H mice.
Howell GE; Mulligan C; Meek E; Chambers JE
Toxicology; 2015 Feb; 328():112-22. PubMed ID: 25541407
[TBL] [Abstract][Full Text] [Related]
31. In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
Lee P; Leong W; Tan T; Lim M; Han W; Radda GK
Hepatology; 2013 Feb; 57(2):515-24. PubMed ID: 22911492
[TBL] [Abstract][Full Text] [Related]
32. cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.
Erion DM; Kotas ME; McGlashon J; Yonemitsu S; Hsiao JJ; Nagai Y; Iwasaki T; Murray SF; Bhanot S; Cline GW; Samuel VT; Shulman GI; Gillum MP
J Biol Chem; 2013 May; 288(22):16167-76. PubMed ID: 23595987
[TBL] [Abstract][Full Text] [Related]
33. NFIL3 is a negative regulator of hepatic gluconeogenesis.
Kang G; Han HS; Koo SH
Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537
[TBL] [Abstract][Full Text] [Related]
34. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
36. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
37. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
You HN; Park MH; Hwang SY; Han JS
J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin.
Mizuno TM; Lew PS; Luo Y; Leckstrom A
Life Sci; 2017 Feb; 170():50-55. PubMed ID: 27914922
[TBL] [Abstract][Full Text] [Related]
39. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB).
Xiao F; Deng J; Jiao F; Hu X; Jiang H; Yuan F; Chen S; Niu Y; Jiang X; Guo F
FASEB J; 2022 Oct; 36(10):e22541. PubMed ID: 36083102
[TBL] [Abstract][Full Text] [Related]
40. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein.
Erion DM; Ignatova ID; Yonemitsu S; Nagai Y; Chatterjee P; Weismann D; Hsiao JJ; Zhang D; Iwasaki T; Stark R; Flannery C; Kahn M; Carmean CM; Yu XX; Murray SF; Bhanot S; Monia BP; Cline GW; Samuel VT; Shulman GI
Cell Metab; 2009 Dec; 10(6):499-506. PubMed ID: 19945407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
